$HLXC Balance Sheet | Understand Stock

$HLXC

$10.29 -$0.01 (0.1%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025
Assets
Current assets
Cash
Due from related parties
Prepaid expenses
Short-term prepaid insurance
Total current assets
Deferred offering costs
Long-term prepaid insurance
Investments held in Trust Account
TOTAL ASSETS
Liabilities and Shareholders’ Deficit
Current liabilities
Accrued offering costs
Accrued expenses
Accounts payable and accrued expenses
Promissory note – related party
Total current liabilities
Deferred underwriting fee payable
Total Liabilities
Class A ordinary shares subject to possible redemption, 17,250,000 shares and 0 shares at redemption value of $10.15 and $0 per share at June 30, 2026 and December 31, 2025, respectively
Class A
Total class A ordinary shares subject to possible redemption, 17,250,000 shares and 0 shares at redemption value of $10.15 and $0 per share at June 30, 2026 and December 31, 2025, respectively
Shareholders’ Deficit:
Ordinary shares, value
Class A
Class B Ordinary Shares
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
Total Liabilities and Shareholders’ Deficit

Comments